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The brain demands high-energy supply and obstruc-
tion of blood flow causes rapid deterioration of the
healthiness of brain cells. Two major events occur
upon ischemia: acidosis and liberation of excess
glutamate, which leads to excitotoxicity. However,
cellular source of glutamate and its release mecha-
nism upon ischemia remained unknown. Here we
show a causal relationship between glial acidosis
and neuronal excitotoxicity. As the major cation
that flows through channelrhodopsin-2 (ChR2) is
proton, this could be regarded as an optogenetic
tool for instant intracellular acidification. Optical acti-
vation of ChR2 expressed in glial cells led to glial
acidification and to release of glutamate. On the
other hand, glial alkalization via optogenetic activa-
tion of a proton pump, archaerhodopsin (ArchT),
led to cessation of glutamate release and to the relief
of ischemic brain damage in vivo. Our results sug-
gest that controlling glial pHmay be an effective ther-
apeutic strategy for intervention of ischemic brain
damage.
INTRODUCTION
Upon brain ischemia, application of thrombolytic agents to
induce reperfusion is the only effective therapeutic intervention
proven. Liberation of excess glutamate upon ischemia is the
direct trigger of neuronal cell death; however, as the cellular
source of glutamate and its release mechanism were unidenti-
fied, targeted intervention to suppress glutamate release has
mostly been unsuccessful (but see Hines and Haydon, 2013).
We focused on the astrocytes of the glial cell population as314 Neuron 81, 314–320, January 22, 2014 ª2014 Elsevier Inc.they are the first responders to ischemic stress (Rossi et al.,
2007). When aerobic metabolism shuts down as a consequence
of oxygen and glucose deprivation, lactate production from
glycogen stored predominantly in glial cells continues (Cataldo
and Broadwell, 1986; Schurr et al., 1997), which leads to severe
acidosis (Mutch and Hansen, 1984). Neuronal cell death via
glutamate excitotoxicity follows (Lau and Tymianski, 2010). We
simply connected these two events and hypothesized that glial
acidosis triggers glial glutamate release. Based on this hypothe-
sis, we sought an optogenetic intervention to control glutamate
release upon ischemia and to understand the cellular mecha-
nisms leading to its excess release.
RESULTS
OGD Induces Glutamate Release and Acidosis
Using acute cerebellar brain slices, ischemia was mimicked by
oxygen and glucose deprivation (OGD) from continuously
perfused artificial cerebrospinal fluid (ACSF) (Hamann et al.,
2005). Neuronal cell health was monitored by whole-cell patch-
clamp recordings from Purkinje cells (PCs) (Figure 1A). Shortly
after the onset of OGD, transient burst firing occurred, which
was followed closely by a plateau depolarization. These events
could be considered as preludes to the eventual death of
neurons. Tomonitor the excitatory drive evoked by OGD in isola-
tion, we recorded PCs in voltage clamp and applied picrotoxin
(PIC) to block inhibitory GABAA receptors. To exclude effects
from neuronal transmitter release and focus on the glial contribu-
tion to ischemic stress, we also applied tetrodotoxin (TTX) and
Cd2+ to block action potentials and voltage-gated Ca2+ chan-
nels, respectively. Within minutes, inward current developed,
suggesting that OGD triggered release of excitatory substance
from nonsynaptic sources, presumably from glia (Figure 1B).
Whether this inward current is evoked by glutamate was
examined with an AMPA receptor blocker alone (GYKI) or with
a cocktail of glutamate receptor and transporter (GluR/T)
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Figure 1. Ischemic Stress Produced Glial Acidosis and Glutamate
Release
(A) Upon OGD, PCs displayed transient burst firing (*), followed by depolari-
zation to a plateau (y). Average time of each event from the OGD onset is
shown (right; burst, n = 5; plateau, n = 6). (B) Excitatory current developed upon
OGD in the presence of TTX, Cd2+, and PIC. Average time to reach –300 pA (*,
n = 22) and –1 nA (y, n = 14) is shown (right). (C) An AMPA receptor blocker (all
units in mM) (100 GYKI53655), glutamate receptor and transporter blockers
(10 NBQX, 200 D-AP5, 100 LY363785, 50 TBOA), or an anion channel blocker
(1,000 DIDS) suppressed OGD-induced PC-current (GYKI, *p < 0.01, n = 6;
GluR/T blocker, *p < 0.01, n = 9; DIDS, *p < 0.01, n = 8). The DIDS effect was
variable between cells (min = 22.8, max = 96.5%). (D) A representative BG
stained with SNARF-5F (left) and the fluorescence change upon OGD, indi-
cating intracellular acidification (middle). Average trace, right (n = 14). Re-
cordings in (B), (C), and (D) were in the presence of TTX, Cd2+, and PIC. Error
bars represent SEM. See also Figure S1.
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Optogenetic Glial Countering of Ischemic Damageblockers (NBQX, D-AP5, LY363785, and TBOA) (Figure 1C).
OGD-induced inward current was significantly blocked in both
cases, demonstrating that the majority of the inward current is
due to glutamate. It should be noted, however, that some current
remained, suggesting that OGD also triggers effects other than
glutamate release. Our previous report has suggested that glial
glutamate release can occur through 4,4’-diisothiocyanostil-
bene-2,20-disulphonic acid (DIDS)-sensitive anion channels
(Sasaki et al., 2012). Application of DIDS also partially inhibited
the OGD-induced inward currents. These results suggest that
release through DIDS-sensitive mechanisms could be one of
the primary sources of excess glutamate liberation upon
ischemia (Camacho et al., 2006; Liu et al., 2006; Seki et al.,
1999), although DIDS-insensitive mechanisms also likely have
a role. It has also been reported that glutamate release can occur
through reversal of glutamate transporters. Extracellular TBOA
has been suggested to block glutamate transporter reversal
(Phillis et al., 2000); however, the development of the OGD-
induced current was only accelerated by TBOA (Figure S1A
available online), likely due to the slower clearance of the
released glutamate by blocking of the uptake by TBOA. There-
fore, we were unable to assess the relative contributions of
each component of glutamate release mechanisms.
Based on previous reports indicating the presence of pH-
dependent anion channels that are DIDS sensitive (Cavelier
and Attwell, 2005; Lambert and Oberwinkler, 2005; Zifarelli
et al., 2008) and pH-dependent amino acid transporters (Sakai
et al., 2003; Weiss et al., 2005), we next sought to examine the
causal link between glial acidification and glutamate release.
First, we verified that glial acidification indeed occurs upon
OGD in acute cerebellar slices by using a pH-sensitive fluores-
cence dye, SNARF-5F AM (Figure 1D and Figures S1B and
S1C). OGD elicited rapid reduction of SNARF-5F fluorescence
ratio in cerebellar Bergmann glial cells (BGs), indicating intracel-
lular acidification. Cells other than BGs were also acidified and
the time course of acidification was examined in granule cells
(GCs), which have similar soma size as the BGs. Interestingly,
the onset of acidification was significantly faster in BGs than
GCs (Figures S1D and S1E).
Acidification Is the Trigger for Glial Glutamate Release
We next attempted to bypass the OGD process and directly
acidify glial cells by optogenetic activation of ChR2. ChR2 is a
light-sensitive cation channel and it is usually considered as a
tool to optically excite cell activity via membrane depolarization.
However, contrary to other excitatory channels such as Na+
channels or ionotropic glutamate receptor channels, ChR2 has
much more permeability to H+ than Na+ (Nagel et al., 2003).
Thus, ChR2 could be considered as an optogenetic tool for
manipulation of intracellular pH. We employed a transgenic
mouse line in which highly light-sensitive mutant (C128S [Berndt
et al., 2009]) of ChR2 was selectively expressed in astrocytes
including BGs using the tetracycline transactivator (tTA)-tet
operator (tetO) system (Tanaka et al., 2012). To confirm proton
influx by ChR2 opening, we measured photocurrents from BGs
with intracellular and extracellular cations mostly replaced with
N-Methyl-D-glucamine (NMDG), a cation with little permeability
to ChR2; thus, the only cation left permeable was protonNeuron 81, 314–320, January 22, 2014 ª2014 Elsevier Inc. 315
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Figure 2. Acidification Is the Trigger for Glial Glutamate Release
(A) Astrocyte-specific ChR2(C128S)-expressing mice were used. H+ perme-
ability of ChR2(C128S) expressed on BGs was assessed by changing the
extracellular pH from 7.4 to 5.0 (top) or 9.0 (bottom). Photocurrent amplitude at
100–200ms from the blue light onset was significantly increased in pH 5.0 (*p <
0.01, n = 5, paired t test) and decreased in pH 9.0 (*p < 0.01, n = 8, paired t test).
Blue and yellow light opens and closes the ChR2(C128S) channel, respec-
tively. (B) pH imaging of BGs with SNARF-5F. A single pulse of blue light
opened the ChR2(C128S) channel for a prolonged time and intracellular
acidification was induced. The acidification was stronger in HEPES compared
to NaHCO3 external buffer (*p < 0.01, n = 12 each, Student’s t test). (C) BG
depolarization amplitude via ChR2(C128S) photoactivation was not affected
by the external pH buffer (p = 0.07, n = 3, paired t test, top), whereas glial
ChR2-photoactivated PC currents became significantly larger by altering the
buffer from NaHCO3 to HEPES compared to NaHCO3 to NaHCO3 (*p < 0.05,
n = 7 and 3, Student’s t test). (D) Application of GYKI, an AMPA receptor-
specific antagonist, blocked glial ChR2-photoactivated PC current in HEPES-
based solution. (E) Exchanging the extracellular solution from NaHCO3-based
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316 Neuron 81, 314–320, January 22, 2014 ª2014 Elsevier Inc.(Figure 2A). Decreasing pH means increasing proton concentra-
tion. Decreasing the external pH from 7.4 to 5.0 enhanced the
photocurrent, whereas increasing the pH from 7.4 to 9.0 reduced
it. These data suggest that our C128S-modified ChR2 expressed
in BGs are also permeable to proton, although it is possible that
ChR2 channel opening itself could be regulated by external pH.
To verify proton influx through ChR2(C128S) in normal intra-
cellular and extracellular solutions, we performed pH imaging,
and BG acidification by ChR2(C128S) photoactivation was
confirmed (Figure 2B). These results indicate that proton influx
occurs upon ChR2 activation; however, if trace amount of
ChR2 is also expressed in intracellular compartments, proton
could enter the cytosol from these sources as well (Gourine
et al., 2010).
We have shown previously that glial ChR2 photoactivation
resulted in glutamate release that could be detected as AMPA
receptor-mediated current in PCs (Sasaki et al., 2012). Consid-
ering the above results, it is possible that proton influx direct
triggers glutamate release; however, it is also possible that
depolarization itself caused by the ChR2 photoactivation or the
very small amount of Ca2+ influx via ChR2 openings could be
the actual trigger. Therefore, we devised a way to cause different
amounts of acidification with the same amount of proton influx
by manipulating the intracellular pH buffering capacity. Intracel-
lular pH is considered to be buffered by HCO3
 and depriving
extracellular HCO3
 would probably cause efflux of intracellular
HCO3
 and result in low buffering capacity of the intracellular pH
(Zhang et al., 2010). Consistent with this idea, acidification
measured by SNARF-5F imaging was significantly stronger in
extracellular 5 mM HEPES buffer solution compared with extra-
cellular NaHCO3 buffer solution, even though both solutions
were adjusted to the same pH (Figure 2B, right). No significant
difference was found in the amplitude of ChR2-induced BG
depolarization upon switching from NaHCO3-based to HEPES-
based solution (Figure 2C, top); however, glial ChR2-photo-
activated PC current was significantly increased (Figure 2C,
bottom). The PC current in HEPES was mostly blocked by
GYKI (Figure 2D), as in the normal NaHCO3 solution (Sasaki
et al., 2012). No current was induced with photostimulation in
BGs or PCs from mice that lack the expression of optogenetic
tools (Figure S2A). Glutamate sensitivity of PC currents was
not increased by switching the external solutions (Figure 2E).
These observations imply that stronger intracellular glial acidifi-
cation leads to larger amount of glutamate release. To test the
H+-triggered glutamate release hypothesis further, we employed
an alternative method to induce intracellular acidification, which
was to locally pressure (puff) apply a weak membrane-perme-
able acid, acetate. This did not induce depolarization of BGs
but did evoke a slow inward current in PCs, which was not de-
tected in the presence of GYKI (Figure S2B). To further excludeto HEPES-based buffer did not increase PC currents in response to glutamate
(200 mM) puff application (n = 5) but rather decreased it. Although we are un-
certain about the mechanism underlying this decrease, this result indicates
that the increase in the glial ChR2-photoactivated PC current upon exchanging
the extracellular solutions (Figure 2C) was not due to the increase in the
glutamate sensitivity of PC glutamate receptors. All recordings were in TTX,
Cd2+, and PIC. Error bars represent SEM. See also Figure S2.
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Figure 3. Glial Alkalization Suppressed OGD-Induced PC Currents
(A) Astrocyte-specific ArchT-expressing mice were used. The bigenic mice,
Mlc1-tTA::tetO-ArchT-EGFP, express ArchT selectively in astrocytes in cere-
bellar cortex. Blue, nuclear staining by H33342; green, EGFP fluorescence. (B)
Immunogold EM of EGFP in the bigenic mice. EGFP was confirmed to be
localized only in the astrocytes (288, 0, 0, and 1 immunogolds in identified
astrocyte, presynaptic, postsynaptic, and unidentifiable profiles, respectively).
Scale bars indicate 500 nm in low- (left) and high- (right) magnified images. (C)
Typical current (left) and voltage (right) responses of BGs to ArchT photo-
activation (yellow). Right: average amplitudes of outward current (n = 9) and
hyperpolarization (n = 6). (D) pH imaging of a BG showed that alkalization was
induced with glial ArchT photoactivation. Right: results summarized (n = 7). (E)
OGD-induced PC currents were reduced by glial ArchT photoactivation (time
constant to reach equilibrium = 1.6 ± 0.2 s, n = 8). The effect was not signifi-
cantly different from the blocking effect of GluR/T blockers (p = 0.27, n = 8, 14,
Student’s t test). ArchT photoactivation effect on PC was significantly reduced
in the presence of GluR/T blockers (*p < 0.05, n = 5, paired t test). (F) Glial
ArchT-photoactivated PC currents were not detected under control condition,
whereas the glial ArchT photoactivation generated outward PC currents during
OGD. Average amplitudes of the outward current (9.5–10 s after yellow light
Neuron
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we examined the effect of puff application of high concentration
of K+. Similar to ChR2 photoactivation, high K+ application
caused BG depolarization, but the current recorded from PCs
was not altered by application of GYKI or NBQX (Figure S2C);
thus, glutamate is not likely to be released as a consequence
of BG depolarization or by high extracellular K+ in the presence
of TTX and Cd2+. The Ca2+ permeability of ChR2 is very low
unless it is specifically modified (Kleinlogel et al., 2011; Li et al.,
2012); thus, Ca2+ influx through these channels is not likely to
be sufficient to drive glial glutamate release (Woo et al., 2012).
To verify this idea, we omitted Ca2+ and added EGTA to the
extracellular solution. The glial ChR2-photoactivated PC current
remained uninhibited in this condition (Figure S2D). It is still
possible that intracellular Ca2+ increase could occur subsequent
to intracellular acidification (Orlowski et al., 2011). To evaluate
whether Ca2+ is involved in the signaling pathway, we strongly
buffered intracellular Ca2+ with BAPTA-AM. Although BAPTA-
AMwas sufficient to strongly suppress neuronal synaptic release
of glutamate (Figure S2E), it did not significantly alter glial ChR2-
photoactivated PC currents (Figure S2F). It still remains possible
that coupling betweenCa2+ source and glutamate releasemech-
anisms is even tighter in glial cells than in synapses; thus, we
could not completely exclude the role of Ca2+ as the intermediate
of acidification and glutamate release.
Countering Glial Acidosis Inhibits Neuronal Damage
If glial acidification were the key trigger of glutamate release
upon ischemia, countering acidification with alkalization should
be able to inhibit glutamate release and excitotoxicity. To selec-
tively increase glial intracellular pH, we generated amouse line in
which astrocyte population of glia, including BGs, specifically
expresses ArchT, a light-sensitive outward proton pump (Han
et al., 2011) using the tTA-tetO system (Tsunematsu et al.,
2013). Immunofluorescence and immunogold electron micro-
scopic observations confirmed specific expression of ArchT in
BGs (Figures 3A and 3B and Figure S3A). ArchT photoactivation
produced outward currents and hyperpolarization in BGs in
voltage- and current-clamp modes, respectively (Figure 3C).
pH imaging also showed that ArchT photoactivation reliably
induced alkalization of BGs (Figure 3D). Glial ArchT photoactiva-
tion dramatically inhibited OGD-induced inward currents in PCs
(Figure 3E). Similar results were obtained at near-physiological
temperature (Figure S3B). Glial ArchT photoactivation alone in
control condition did not evoke any current in PCs and the effect
was only evident in OGD (Figure 3F); thus, proton efflux from glia
or other ionic change does not directly produce any current in
PCs. Furthermore, the blocking effect of glial ArchT photoactiva-
tion on OGD-induced PC currents was nearly equal to that of
GluR/T blocker application (Figure 3E,middle) andwas occluded
in the presence of GluR/T blockade (Figure 3E, right). As DIDS
could only block half of the OGD-induced current (Figure 1C)
and, as the ArchT effect was only partially occluded by DIDS
(Figure S3C), there likely exists DIDS-sensitive and -insensitiveapplication) were summarized (n = 7 each). Recordings in (D), (E), and (F) were
in the presence of TTX, Cd2+, and PIC. Error bars represent SEM. See also
Figure S3.
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Figure 4. Glial Alkalization by ArchT Photoactivation Relieved
Ischemic Brain Damage
(A) OGD-induced PC-currents without (top) and with (bottom) intermittent glial
ArchT photoactivation. PC currents reaching –300 pA and –1 nA are indicated
by * and y, respectively. Percentage of cells displaying inward currents of >1 nA
within the time indicated is summarized (right). The bottom trace (boxed area)
is magnified on right and the current trace before decimating the data points is
shown in gray. (B) Current-clamp recording from PCs without (top) and with
(bottom) intermittent glial ArchT photoactivation. Transient burst firing and the
onset of plateau depolarization are indicated by * and y, respectively. Per-
centage of cells reaching plateau depolarization is summarized (right). The
bottom trace (boxed area) is magnified on right. (C) Left: schematic illustration
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318 Neuron 81, 314–320, January 22, 2014 ª2014 Elsevier Inc.glial glutamate release mechanisms, both of which are pH sensi-
tive. As glutamate uptake by glutamate transporters is voltage
dependent (Bergles et al., 1997), it is possible that glutamate
release is not suppressed but the uptake is facilitated in glia,
which is hyperpolarized by ArchT photoactivation. To examine
this possibility, we induced OGD in the presence of TBOA. Glial
ArchT photoactivation blocked OGD-induced PC currents simi-
larly, even in the presence of TBOA (Figure S3D). Taken together,
these data suggest that glial pH change is an upstream causal
factor of glutamate release upon ischemia.
We next examined whether intermittent glial ArchT photo-
activation could prevent deterioration of the healthiness of
neurons upon ischemia. Excitatory drive recorded from PCs in
voltage clamp rapidly increased upon OGD and over 1 nA of
inward current was observed within 20 min. We next introduced
intermittent glial ArchT photoactivation after detecting in-
ward currents of more than 300 pA. Further development of
inward current was prominently suppressed (Figure 4A). The in-
ward current could not be suppressed completely, suggesting
the presence of additional unidentified mechanisms that lead
to the increased conductance. Similarly, in current-clamp re-
cordings from PCs in the absence of pharmacological agents,
glial ArchT photoactivation was introduced after burst firing
emerged upon OGD (Figure 4B). Without the photoactivation,
PCs soon reached plateau depolarization, whereas photoactiva-
tion suppressed this indication of cell deterioration.
Could simply countering acidosis with glial alkalization exert
a neuroprotective action upon ischemia? To answer this ques-
tion, ischemia in the cerebellum in vivo was created by using a
photosensitive dye, rose bengal (Watson et al., 1985). Rose
bengal was injected intra-arterially and focal ischemic region
was created by exciting this dye via an optic fiber placed above
the cerebellum and thrombosis was artificially created. Three
hours after creation of thrombosis, severe neuronal degenera-
tion was confirmed (Figure 4C). To quantify the level of damage,
we scored brain sections based on the relative loss of PCs and
the degenerated area (Figure S4). In one group of mice, glial
ArchT photoactivation was intermittently applied from 0.5 to
2.5 hr after the creation of thrombosis. In this group, progressive
generation of infarct area was significantly inhibited at 3 hr from
photothrombosis (Figures 4D and 4E). These results demon-
strate that countering of astrocyte acidosis can reduce brain
damage upon ischemia.
DISCUSSION
Evidence for glia modulating neuronal activity (Panatier et al.,
2011; Saab et al., 2012) and glutamate being used as gliotrans-
mitter is accumulating (Woo et al., 2012); however, theof the creation of cerebellar ischemia with artificial thrombosis. Right: typical
images of calbindin immunostaining of the cerebellum in a rose bengal-in-
jected (Thrombosis) and noninjected mouse (Sham). Boxes indicate the
approximate region of illumination. (D) Representative images of cerebellum
from astrocyte-specific ArchT-expressing mice not exposed (left) and
exposed (right) to intermittent glial ArchT photoactivation. (E) Scores of
ischemic brain damage with higher numbers indicating more severe damage
(n = 17 and 19 mice, p < 0.01, Wilcoxon ranked-sum test). See also Figure S4.
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reports have indicated that the release is Ca2+ dependent
(Halassa and Haydon, 2010), although functional significance
of glial Ca2+ has also been questioned (Agulhon et al., 2010;
Sun et al., 2013). Here, we propose that glial pH changes are a
significant regulator of glutamate release in the cerebellum. We
focused on the cerebellum because of the close morphological
apposition of glial and neuronal elements that suggests that, if
there is any commitment of glial cell activities in physiological
or pathophysiological circumstances, it could manifest most in
the cerebellum. As pH-dependent glial ATP release has also
been shown (Gourine et al., 2010), pH could be a key glial intra-
cellular signal, which is as pivotal as Ca2+, although the relative
importance of pHmay differ among different brain regions (Kasy-
mov et al., 2013).
It should be noted that we are not proposing that H+-triggered
glial glutamate release is the only mechanism underlying libera-
tion of excess glutamate upon ischemia. Most of the current
experiments were done in TTX and Cd2+ to focus on the glial
component, but neurons have also been shown to release gluta-
mate during the initial stage of ischemia by vesicular release, and
reversal of neuronal and glial glutamate transporters has also
been shown to occur (Gebhardt et al., 2002; Hamann et al.,
2005; Rossi et al., 2007). The relative role of each component
is difficult to assess, as blocking one component will also disrupt
the interplay between all components. However, our data do
show that suppression of glial glutamate release alone by glial
ArchT photoactivation can sustain hyperpolarization of neurons
in half of the cells in slices in the absence of all pharmacological
agents for some time (Figure 4B) and save the brain from large
structural damage in vivo (Figure 4D).
Direct application of our findings in patients is limited, as
it would require preemptive gene therapy before ischemia.
However, our data do show that countering of glial acidosis
alone can powerfully suppress ischemic brain damage, which
suggests that pH-dependent glial glutamate release is one of
the pathways leading to excitotoxic cell death. Therapeutic strat-
egy could involve simple delivering of cell-permeable strong
pH buffer or pharmacological agents directed to facilitate H+
exchange. As glial ChR2-photoactivated PC current was not
sensitive to NPPB (Sasaki et al., 2012), the glutamate release
mechanism is not likely to be via Best1 (Woo et al., 2012). Other
various anion channels and transporters have been reported to
deliver glutamate to extracellular space with different pharmaco-
logical characteristics (Fields and Ni, 2010); however, most of
their molecular identity has not been specified. If we are able
to find which channel or transporter is involved in the pH-depen-
dent glial glutamate release, targeted drug design would
become plausible.
EXPERIMENTAL PROCEDURES
All experiments were performed in accordance with the guidelines of the Phys-
iological Society of Japan.
Electrophysiology
Acute slice preparation andwhole-cell patch-clamp recording were performed
as described previously (Sasaki et al., 2012). To simulate energy deprivation
upon brain ischemia, we omitted glucose and superfusate bubbled with95% N2, 5% CO2 was used. For most experiments, photostimulation was
delivered to the slices through the objective lens, but for the ArchT activation
during pH imaging, photostimulation was given through the condenser lens as
described in the Supplemental Experimental Procedures.
pH Imaging
Cells were loaded with local puff application of SNARF-5F AM. In most record-
ings, SNARF-5F was excited with 810 nm two-photon laser and fluorescence
was detected using two emission filters (586/20 nm and 650/60 nm) and the
fluorescence ratio (R650/586) was calculated. Details are described in Supple-
mental Experimental Procedures.
Optogenetic Mice
tetO-ChR2(C128S)-EYFP b-actin gene locus knockin mice (Tanaka et al.,
2012), tetO-ArchT-EGFP b-actin gene BAC transgenic mice (Tsunematsu
et al., 2013), and astrocyte specific Mlc1-tTA mice (Sasaki et al., 2012; Tanaka
et al., 2010) were used. Bigenic mice were created by crossing the Mlc1-tTA
with either of the tetO lines. Details are described in the Supplemental Exper-
imental Procedures.
Immunogold Electron Microscopy of Mlc1-tTA::tetO-ArchT-EGFP
Mice
Tissue processing for preembedding immunoelectron microscopy was
performed as described previously (Parajuli et al., 2012). Mouse anti-GFP
antibody (1 mg/ml, Clone mFX73, Wako) was used as a primary antibody,
and enhancement of the immunogold particles was carried out by using a
gold enhance-EM kit (Nanoprobes). Details are described in the Supplemental
Experimental Procedures.
Creation of Cerebellar Ischemia Model and In Vivo Glial ArchT
Photoactivation
Rose bengal was administrated through the left carotid artery (Watson et al.,
1985) and the dye was excited for 4–5min via an optical fiber placed just above
the craniotomy made over the cerebellum. A group of mice was given inter-
mittent glial ArchT photoactivation (1 s light on, 1 s light off cycle for 2.5 hr),
which started after 30min from the photothrombosis. Themice were sacrificed
after 3 hr from the photothrombosis. Details of the evaluation of the infarct area
are described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.neuron.2013.11.011.
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